Keywords: chiroscience, cancer, drug, starts, trials, started, phase

Chiroscience Cancer Drug Starts Trials

Article | 08 January 1998

Chiroscience has started Phase I clinical testing of D2163, a matrixmetalloproteinase inhibitor which is being developed for preventing the growth ...

Enjoying this article? To continue reading you need to login or subscribe.

Subscribe now
for unlimited access to all articles

Subscriptions are £60 per month, pay as you go.
Find out more details.

Already a subscriber? Click here to log in

Related Companies

Bayer

Sankyo

Go to company listing

Related Drugs

Aspirin

Bayer

Go to drug listing